Psilocybin is a compound that occurs naturally in over 150 species of mushrooms world-wide.
The United States Federal Drug Agency recently designated psilocybin "Breakthrough Therapy"status for it's role in treating treatment-resistant depression and major depressive disorder.
Psilocybin is far safer than current methods of treating depression and offers a unique path for millions of Americans who suffer from the debilitating disease.
Unfortunately, psilocybin is currently a Schedule 1 Drug in Tennessee. This means that possession of any of the 150 species of mushrooms that contain psilocybin will incur thousands of dollars in fines and a prison sentence.
Phase III clinical trials will be completed in 2020. Researchers will suggest categorizing the drug as schedule IV if trials are successful.